ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
Clinical trials for ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to stop Cancer's return: two drugs face off in major blood cancer trial
Disease control Recruiting nowThis study aims to find the best maintenance therapy to prevent cancer from returning in patients with a specific genetic type of acute myeloid leukemia (AML) who have received a stem cell transplant. Researchers will compare two drugs, gilteritinib and sorafenib, given for two y…
Matched conditions: ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New pill aims to keep deadly leukemia at bay after risky transplant
Disease control Recruiting nowThis study is testing whether a pill called Chidamide can help prevent a dangerous blood cancer (AML) from coming back after a stem cell transplant. It will involve about 134 patients who are at high risk of the cancer returning. One group will take the pill for up to two years, …
Matched conditions: ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test 'Smarter' transplant to fight blood cancers with fewer side effects
Disease control Recruiting nowThis early-stage trial is testing a new approach to stem cell transplants for adults with advanced blood cancers like leukemia. Researchers are modifying the donor cells by adding specific immune cells (regulatory T-cells) alongside the standard transplant. The goal is to help th…
Matched conditions: ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC